✦ LIBER ✦

Infliximab for postsurgical endoscopic recurrence of Crohn's disease: No trumpets yet

✍ Scribed by D. Sorrentino; A. Paviotti

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 50 KB
Volume: 15
Category: Article
ISSN: 1078-0998
DOI: 10.1002/ibd.20965

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oral contrast-enhanced sonography for th

Oral contrast-enhanced sonography for the diagnosis and grading of postsurgical recurrence of Crohn's disease

✍ Fabiana Castiglione; Luigi Bucci; Giuseppe Pesce; Giovanni Domenico De Palma; Lu 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB 👁 1 views

Background: Postsurgical recurrence (PSR) is very common in patients with Crohn's disease (CD) and previous surgery. Endoscopy is crucial for the diagnosis of PSR, also showing high prognostic value. Bowel sonography (BS) with or without oral contrast enhancement (OCBS) is accurate for CD diagnosis

Impact of infliximab therapy after early

Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn's disease: A prospective pilot study

✍ Takayuki Yamamoto; Satoru Umegae; Koichi Matsumoto 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 1 views

## Background: The efficacy of infliximab for endoscopic recurrence after resection of Crohn's disease (CD) has not yet been reported. The aim of this prospective study was to investigate the impact of infliximab on early endoscopic lesions after resection for CD. Methods: Twenty-six patients main